| scholarly article | Q13442814 |
| P2093 | author name string | Daniel J Goldstein | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | II272-7 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation | |
| P478 | volume | 108 Suppl 1 |
| Q36988852 | A novel mathematical model of activation and sensitization of platelets subjected to dynamic stress histories. |
| Q35875346 | A phenomenological particle-based platelet model for simulating filopodia formation during early activation |
| Q42337826 | Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients |
| Q50970967 | Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: a case series. |
| Q34159316 | Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device |
| Q37572585 | Computational Analysis of Pumping Efficacy of a Left Ventricular Assist Device according to Cannulation Site in Heart Failure with Valvular Regurgitation. |
| Q44560980 | Computational analysis of the effect of the type of LVAD flow on coronary perfusion and ventricular afterload |
| Q28731568 | Device thrombogenicity emulation: a novel method for optimizing mechanical circulatory support device thromboresistance |
| Q85019819 | Hematologic Effects of Continuous Flow Left Ventricular Assist Devices |
| Q38017154 | Indications for heart transplantation in current era of left ventricular assist devices |
| Q26782700 | Late Complications Following Continuous-Flow Left Ventricular Assist Device Implantation |
| Q37067918 | Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries |
| Q91938871 | Management and outcomes of left ventricular assist device-associated endocarditis: a systematic review |
| Q43920468 | Mechanical Circulatory Support for Advanced Heart Failure |
| Q36160909 | Mechanical circulatory support devices (MCSD) in Japan: current status and future directions |
| Q33371447 | Mechanical circulatory support: a clinical reality |
| Q37991198 | Mechanical circulatory support: devices, outcomes and complications |
| Q37167797 | Mechanical support in acute and chronic heart failure |
| Q47186874 | Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation |
| Q38076112 | Past and present of cardiocirculatory assist devices: a comprehensive critical review. |
| Q36723283 | Pediatric ventricular assist devices |
| Q35999513 | Perioperative pharmacotherapy in patients with left ventricular assist devices |
| Q37826020 | Pharmacotherapy for mechanical circulatory support: a comprehensive review |
| Q35453157 | Preoperative liver dysfunction influences blood product administration and alterations in circulating haemostatic markers following ventricular assist device implantation |
| Q64246593 | Protected percutaneous coronary intervention with Impella CP in a patient with left main disease, severe left ventricular systolic dysfunction and established hemolysis |
| Q48956086 | Quantification of the secondary flow in a radial coupled centrifugal blood pump based on particle tracking velocimetry |
| Q41852891 | Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance. |
| Q40237072 | Surgical therapy for heart failure |
| Q37599866 | The future is here: ventricular assist devices for the failing heart |
| Q51232492 | Transradial unprotected left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device. |
| Q36315026 | Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure |
| Q36694088 | Ventricular assist devices (VAD) therapy: new technology, new hope? |
| Q36253045 | Ventricular assist devices and anesthesia |
Search more.